$1.14B
$390,000
0.0% of portfolio
79,596
Q4 2023
Reduced 58.86%
$2.13B
$384,000
0.0% of portfolio
4,139
Q4 2023
Reduced 2.84%
$1.39B
$1.15 Million
0.0% of portfolio
92,927
Q4 2023
Reduced 3.06%
$1.59B
$387,000
0.0% of portfolio
10,648
Q4 2023
Added 7.38%
$871M
$813,000
0.0% of portfolio
27,137
Q4 2023
Reduced 3.06%
$23.3B
$1.36 Million
0.0% of portfolio
18,309
Q4 2023
Added 114.47%
$7.14B
$3.27 Million
0.0% of portfolio
21,612
Q4 2023
Reduced 11.6%
$4.73B
$427,000
0.0% of portfolio
514,617
Q4 2023
Added 62.75%
$2.52B
$984,000
0.0% of portfolio
11,602
Q4 2023
Reduced 3.0%
$70.3B
$221,000
0.0% of portfolio
808
Q1 2023
Added 3.19%
$52.9B
$216,000
0.0% of portfolio
1,588
Q4 2023
Added 2.52%
-
$0
0.0% of portfolio
-
Q4 2023
Reduced 26.96%
-
$0
0.0% of portfolio
-
Q4 2023
Reduced 98.76%
-
$0
0.0% of portfolio
-
Q4 2023
Added 10.72%
$2.2B
$715,000
0.0% of portfolio
3,402
Q4 2023
Added 6.05%
$7.92B
$2.37 Million
0.0% of portfolio
176,180
Q4 2023
Added 7.94%
-
$0
0.0% of portfolio
-
Q4 2023
Reduced 97.79%
$2.53B
$480,000
0.0% of portfolio
4,895
Q4 2023
Reduced 2.92%
$43.5B
$1.03 Million
0.0% of portfolio
13,234
Q4 2023
Added 110.53%
$1.27B
$852,000
0.0% of portfolio
44,846
Q4 2023
Reduced 3.06%
$2.98B
$3.28 Million
0.0% of portfolio
518,942
Q4 2023
Added 9.41%
$229B
$468,000
0.0% of portfolio
6,050
Q4 2023
Reduced 2.2%
$4.96B
$2.58 Million
0.0% of portfolio
92,956
Q4 2023
Added 19.6%
$446M
$236,000
0.0% of portfolio
8,494
Q4 2023
Reduced 3.0%
$11.6B
$3.32 Million
0.0% of portfolio
57,045
Q4 2023
Reduced 11.73%
$32.8B
$3.26 Million
0.0% of portfolio
17,055
Q4 2023
New
Alnylam Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q4 2023
Reduced 19.12%
$3.35B
$2.69 Million
0.0% of portfolio
7,945
Q4 2023
Reduced 22.04%
-
$0
0.0% of portfolio
-
Q4 2023
Added 26.63%
Amalgamated Financial Corp
-
$0
0.0% of portfolio
-
Q4 2023
Added 25.74%
$3.13B
$386,000
0.0% of portfolio
6,304
Q4 2023
Added 7.63%
$28.3B
$334,000
0.0% of portfolio
119,455
Q4 2023
Added 2.01%
$1.48B
$381,000
0.0% of portfolio
16,929
Q4 2023
Reduced 3.03%
$650M
$1.51 Million
0.0% of portfolio
171,037
Q4 2023
Reduced 3.08%
$3.22B
$360,000
0.0% of portfolio
17,047
Q4 2023
New
$0
$2.44 Million
0.0% of portfolio
43,671
Q4 2023
Reduced 4.23%
$161M
$226,000
0.0% of portfolio
20,609
Q4 2023
Reduced 24.25%
$2.48B
$315,000
0.0% of portfolio
211,923
Q4 2023
New
$1.36B
$1.59 Million
0.0% of portfolio
17,168
Q4 2023
Added 2.12%
$43.3B
$3.31 Million
0.0% of portfolio
20,057
Q4 2023
Reduced 87.28%
$1.16B
$398,000
0.0% of portfolio
5,323
Q4 2023
Added 28.64%
$1.29B
$422,000
0.0% of portfolio
69,593
Q4 2023
Reduced 54.4%
$46.3B
$214,000
0.0% of portfolio
2,164
Q4 2023
New
$222M
$311,000
0.0% of portfolio
52,579
Q4 2023
Reduced 3.08%
$115B
$361,000
0.0% of portfolio
1,820
Q3 2023
Reduced 1.52%
$1.46B
$1.67 Million
0.0% of portfolio
29,009
Q4 2023
Added 24.94%
$472M
$384,000
0.0% of portfolio
49,027
Q4 2023
Reduced 3.06%
$7.88B
$251,000
0.0% of portfolio
20,036
Q4 2023
Reduced 11.16%
$440M
$1.45 Million
0.0% of portfolio
179,171
Q4 2023
Added 30.52%
$76B
$215,000
0.0% of portfolio
739
Q3 2023
Reduced 1.34%